Your browser doesn't support javascript.
Reduced circulating BMP9 and pBMP10 in hospitalized COVID-19 patients.
Dunmore, Benjamin J; Upton, Paul D; Auckland, Kate; Samanta, Romit J; Lyons, Paul A; Smith, Kenneth G C; Gräf, Stefan; Summers, Charlotte; Morrell, Nicholas W.
  • Dunmore BJ; Heart and Lung Research Institute University of Cambridge Cambridge UK.
  • Upton PD; Department of Medicine University of Cambridge School of Clinical Medicine Cambridge UK.
  • Auckland K; Heart and Lung Research Institute University of Cambridge Cambridge UK.
  • Samanta RJ; Department of Medicine University of Cambridge School of Clinical Medicine Cambridge UK.
  • Lyons PA; Heart and Lung Research Institute University of Cambridge Cambridge UK.
  • Smith KGC; Department of Medicine University of Cambridge School of Clinical Medicine Cambridge UK.
  • Gräf S; Cambridge University Hospitals and Royal Papworth Hospital NHS Foundation Trust Cambridge UK.
Pulm Circ ; 13(1): e12192, 2023 Jan.
Article in English | MEDLINE | ID: covidwho-2219862
ABSTRACT
Similar to other causes of acute respiratory distress syndrome, coronavirus disease 2019 (COVID-19) is characterized by the aberrant expression of vascular injury biomarkers. We present the first report that circulating plasma bone morphogenetic proteins (BMPs), BMP9 and pBMP10, involved in vascular protection, are reduced in hospitalized patients with COVID-19.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Pulm Circ Year: 2023 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Pulm Circ Year: 2023 Document Type: Article